skip to main content
Idioma:
Refinado por: assunto: Cell Biology remover Blood remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Plasma Zinc Level and Thymic Hormone Activity in Young Cancer Patients
Plasma Zinc Level and Thymic Hormone Activity in Young Cancer Patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Plasma Zinc Level and Thymic Hormone Activity in Young Cancer Patients

Mocchegiani, Eugenio ; Paolucci, Paolo ; Granchi, Donatella ; Cavallazzi, Laura ; Santarelli, Lory ; Fabris, Nicola

Blood, 1994-02, Vol.83 (3), p.749-757 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
2
Molecular Analysis of 11q13 Breakpoints in Multiple Myeloma
Molecular Analysis of 11q13 Breakpoints in Multiple Myeloma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Molecular Analysis of 11q13 Breakpoints in Multiple Myeloma

Ronchetti, Domenica ; Finelli, Palma ; Richelda, Raffaella ; Baldini, Luca ; Rocchi, Mariano ; Viggiano, Luigi ; Cuneo, Antonio ; Bogni, Silvia ; Fabris, Sonia ; Lombardi, Luigia ; Maiolo, Anna Teresa ; Neri, Antonino

Blood, 1999-02, Vol.93 (4), p.1330-1337 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
3
Platelet-associated autoantibodies as detected by a solid-phase modified antigen capture ELISA test (MACE) are a useful prognostic factor in idiopathic thrombocytopenic purpura
Platelet-associated autoantibodies as detected by a solid-phase modified antigen capture ELISA test (MACE) are a useful prognostic factor in idiopathic thrombocytopenic purpura
Material Type:
Artigo 		Adicionar ao Meu Espaço

Platelet-associated autoantibodies as detected by a solid-phase modified antigen capture ELISA test (MACE) are a useful prognostic factor in idiopathic thrombocytopenic purpura

Fabris, Fabrizio ; Scandellari, Raffaella ; Ruzzon, Elisabetta ; Randi, Maria Luigia ; Luzzatto, Guido ; Girolami, Antonio

Blood, 2004-06, Vol.103 (12), p.4562-4564 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
4
Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)
Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)

Bassan, Renato ; Spinelli, Orietta ; Oldani, Elena ; Intermesoli, Tamara ; Tosi, Manuela ; Peruta, Barbara ; Rossi, Giuseppe ; Borlenghi, Erika ; Pogliani, Enrico M. ; Terruzzi, Elisabetta ; Fabris, Pietro ; Cassibba, Vincenzo ; Lambertenghi-Deliliers, Giorgio ; Cortelezzi, Agostino ; Bosi, Alberto ; Gianfaldoni, Giacomo ; Ciceri, Fabio ; Bernardi, Massimo ; Gallamini, Andrea ; Mattei, Daniele ; Di Bona, Eros ; Romani, Claudio ; Scattolin, Anna Maria ; Barbui, Tiziano ; Rambaldi, Alessandro

Blood, 2009-04, Vol.113 (18), p.4153-4162 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
5
Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma
Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma

Lionetti, Marta ; Biasiolo, Marta ; Agnelli, Luca ; Todoerti, Katia ; Mosca, Laura ; Fabris, Sonia ; Sales, Gabriele ; Deliliers, Giorgio Lambertenghi ; Bicciato, Silvio ; Lombardi, Luigia ; Bortoluzzi, Stefania ; Neri, Antonino

Blood, 2009-12, Vol.114 (25), p.e20-e26 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
6
Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study
Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study

Saleh, Mansoor N. ; Bussel, James B. ; Cheng, Gregory ; Meyer, Oliver ; Bailey, Christine K. ; Arning, Michael ; Brainsky, Andres

Blood, 2013-01, Vol.121 (3), p.537-545 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.